MedTrace Logo

Clinical Evaluation of Efficacy of SLT to Topical Medication in Lowering IOP

NCT01639807 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2012-07-13

No results posted yet for this study

Summary

The purpose of this study is to compare Selective laser trabeculoplasty (SLT) and topical medications for initial treatment of open-angle glaucoma /Ocular Hypertension based on intraocular pressure reduction, treatment side effects, quality of life measures and costs in South Indian Population.

Conditions

Interventions

DRUG

Latanoprost

Latanoprost (0.005%) eye drops, once daily in the evening

PROCEDURE

SLT

Selective Laser Trabeculoplasty

Sponsors & Collaborators

  • Aurolab

    lead OTHER

Principal Investigators

  • GEORGE V PUTHURAN, M.B.B.S, M.S · Aravind Eye Hospital,Madurai.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2013-10-31
Completion
2014-12-31

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01639807 on ClinicalTrials.gov